Skip to main content
KALA
NASDAQ Life Sciences

KALA BIO Sets November 3 Vote on Reverse Split Up to 1-for-300 to Regain Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.529
Mkt Cap
$10.83M
52W Low
$0.49
52W High
$988.5
52W Position info
7.9% above low
Off High info
100% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

KALA is trading near its 52-week low of $0.49 (7.9% above the low) on elevated volume (2.0× avg).

Summary

KALA BIO's definitive proxy sets a November 3 vote on a reverse stock split of up to 1-for-300 to address its Nasdaq delisting notice. The board would choose the exact ratio within a 1-for-2 to 1-for-300 range.


Key Events · Corporate Governance and Compliance · KALA

  • Reverse Split Vote Set for Nov 3

    Shareholders will vote on a reverse stock split at a ratio between 1-for-2 and 1-for-300, with the board choosing the exact ratio and timing. The company received a Nasdaq delisting determination on August 28, 2026.

  • 19.3M Shares Outstanding

    As of the September 10 record date, 19,339,786 shares were outstanding. A 1-for-300 split would reduce this to approximately 64,000 shares.

  • Board Discretion on Ratio

    The board may elect not to proceed with the reverse split at all, or choose any ratio within the approved range. The wide range signals preparation for a severe price decline scenario.

  • Nasdaq Compliance Pressure

    The reverse split is explicitly intended to support compliance with Nasdaq continued listing requirements after the stock traded below $1.00 for 30 consecutive business days.


Analysis · KALA · Life Sciences

KALA BIO's definitive proxy sets a November 3, 2026 shareholder vote on a reverse stock split ranging from 1-for-2 to 1-for-300, with the board holding discretion on the exact ratio. The company received a Nasdaq delisting determination on August 28 after trading below $1.00 for 30 consecutive business days, and this reverse split is the primary mechanism to regain compliance. With 19.3 million shares outstanding and a stock price around $0.53, the board is seeking maximum flexibility — a 1-for-300 split would reduce the share count to roughly 64,000 shares and mechanically lift the price well above $1.00, but at the cost of extreme illiquidity and potential further shareholder value erosion. The proxy also includes routine items: election of two Class III directors, say-on-pay, and ratification of HTL International as auditor. The reverse split proposal is the market-moving item here — approval would give the board a tool to avoid delisting, but the wide ratio range signals the company is preparing for a worst-case scenario.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, KALA was trading at $0.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $0.49 to $988.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KALA - Latest Insights

KALA
Nov 16, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.49
Real-time Price: $3.57 info
Change: Reverse Stock Split info
Market Cap: $2.684M info
KALA
Nov 12, 2026, 8:00 AM EST
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.149
Real-time Price: $3.57 info
Change: Reverse Stock Split info
Market Cap: $2.684M info
KALA
Nov 09, 2026, 8:00 AM EST
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.1568
Real-time Price: $3.57 info
Change: Reverse Stock Split info
Market Cap: $2.684M info
KALA
Sep 29, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.474
Real-time Price: $3.57 info
Change: Reverse Stock Split info
Market Cap: $2.684M info
KALA
Sep 11, 2026, 4:56 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $3.57 info
Change: Reverse Stock Split info
Market Cap: $2.684M info